Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study
Go back to Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.92 +0.07 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.85 | 52 Week High | $39.41 | |||
| Open | $101.59 | 52 Week Low | $25.98 | |||
| Day High | $103.57 | P/E | 144.96 | |||
| Day Low | $101.51 | EPS | $0.71 | |||
| Volume | 424,678 | |||||
| (NASDAQ: OBIO) | Delayed: 5.08 +0.34 (7.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.74 | 52 Week High | $ | |||
| Open | $4.71 | 52 Week Low | $ | |||
| Day High | $5.14 | P/E | N/A | |||
| Day Low | $4.71 | EPS | $ | |||
| Volume | 478,138 | |||||
